These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 6226856)
61. Host resistance to tumor after cure of advanced LSA lymphoma by treatment with BCNU and chlorozotocin. Feola J; Maruyama Y Cancer Treat Rep; 1979 Aug; 63(8):1409-12. PubMed ID: 157809 [TBL] [Abstract][Full Text] [Related]
62. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity. Fox PA; Panasci LC; Schein PS Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478 [TBL] [Abstract][Full Text] [Related]
63. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer]. Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810 [TBL] [Abstract][Full Text] [Related]
64. Paclitaxel (1-hour) and carboplatin (area under the concentration-time curve 7.5) in advanced non-small cell lung cancer: a phase II study of the Fox Chase Cancer Center and its network. Langer CJ; Millenson M; Rosvold E; Litwin S; McAleer CA; Bonjo CA; Ozols R Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-81-S12-88. PubMed ID: 9331128 [TBL] [Abstract][Full Text] [Related]
65. [Outpatient chemotherapy with infusional 5-fluorouracil in advanced gastrointestinal cancer]. Tsuji Y; Miyajima N; Kuroiwa G; Kato M; Nobuoka A; Ohi M; Honjo K Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():346-50. PubMed ID: 10630245 [TBL] [Abstract][Full Text] [Related]
66. Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers. Leichman CG; Leichman L; Spears CP; Rosen PJ; Muggia F; Jeffers S; Waugh W Cancer Chemother Pharmacol; 1990; 26(1):57-61. PubMed ID: 2182214 [TBL] [Abstract][Full Text] [Related]
68. A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer. Roberto M; Romiti A; Onesti CE; D'Antonio C; Milano A; Falcone R; Barucca V; Palombi L; Righini R; Marchetti P Anticancer Drugs; 2016 Feb; 27(2):106-11. PubMed ID: 26473528 [TBL] [Abstract][Full Text] [Related]
69. Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas. Blair SC; Zalupski MM; Baker LH Am J Clin Oncol; 1994 Dec; 17(6):480-4. PubMed ID: 7977164 [TBL] [Abstract][Full Text] [Related]
70. Combination paclitaxel (1-hour) and carboplatin (AUC 7.5) in advanced non-small cell lung cancer: a phase II study by the Fox Chase Cancer Center Network. Langer CJ; Millenson M; O'Dwyer P; Kosierowski R; Alexander R; Litwin S; McAleer CA; Bonjo CA; Ozols R Semin Oncol; 1996 Dec; 23(6 Suppl 16):35-41. PubMed ID: 9007119 [TBL] [Abstract][Full Text] [Related]
71. Chlorozotocin, an anti-tumour agent lacking bone marrow toxicity at therapeutic doses: effects on lymphocyte subpopulations in mice. Fisher RI; Mandell GL; Bostick F; McMenamin MG; Anderson T Clin Exp Immunol; 1980 Feb; 39(2):416-25. PubMed ID: 6446427 [TBL] [Abstract][Full Text] [Related]
72. High-dose chlorozotocin in lung cancer: a Southwest Oncology Group Phase II Study. Haas CD; Stephens RL; Bukowski RM; Stuckey WJ; McCracken JD; Gagliano RG; Lehane DE; Pugh RP Cancer Treat Rep; 1983; 67(7-8):705-7. PubMed ID: 6223694 [No Abstract] [Full Text] [Related]